Please use this identifier to cite or link to this item:
https://hdl.handle.net/11499/51033
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Öztürk, Şevval | - |
dc.contributor.author | Cüneyit, İbrahim | - |
dc.contributor.author | Altuntaş, Fatih | - |
dc.contributor.author | Karagür, Ege Rıza | - |
dc.contributor.author | Cort Dönmez, Ayşegül | - |
dc.contributor.author | Ocak, Mert | - |
dc.contributor.author | Ünal, Mustafa | - |
dc.contributor.author | Sarikanat, Mehmet | - |
dc.contributor.author | Donmez, Baris Ozgur | - |
dc.date.accessioned | 2023-06-13T19:08:07Z | - |
dc.date.available | 2023-06-13T19:08:07Z | - |
dc.date.issued | 2023 | - |
dc.identifier.issn | 0914-8779 | - |
dc.identifier.issn | 1435-5604 | - |
dc.identifier.uri | https://doi.org/10.1007/s00774-023-01416-z | - |
dc.identifier.uri | https://hdl.handle.net/11499/51033 | - |
dc.description.abstract | IntroductionOsteoporosis is a major health problem that is very common worldwide and is characterized by both low bone density and deterioration in bone quality. New treatment options without side effects have become an active area of research in recent years. This study was designed to investigate the preventive effects of resveratrol on bone quality deterioration caused by ovariectomy.Materials and MethodsSixty rats were randomly divided into five groups (12 animals per group): Control, Sham-operated (SHAM), ovariectomized (OVX), OVX + Resveratrol-40 mg/kg/day (OVX + Res40), OVX + Resveratrol-80 mg/kg/day (OVX + Res80). Resveratrol was administered by oral gavage (40 and 80 mg/kg/day) for ten weeks. Micro-CT measurements, biomechanical testing, Raman spectroscopy analysis, and RT-PCR analysis were performed. ALP, OCN, TAS, and TOS levels were also measured from blood serum.ResultsBone strength, bone volume/total volume, trabecular volume, and trabecular thickness were higher in the OVX + RES-80 group than in the OVX group. Resveratrol increased osteogenic differentiation, as the expression of osteogenic markers ALP, Col1A1, Runx2, OPG, OCN increased in both OVX + RES-80 and OVX + RES-40 groups compared to the OVX group. 80 mg/kg/day resveratrol administration decreased the levels of ALP, OCN and TOS in ovariectomized rats. Raman spectroscopy findings showed a preventive effect of resveratrol administration against ovariectomy-induced deterioration in biophysiochemical properties of bone tissue.ConclusionThis study revealed that administration of different doses of 80 mg/kg/day and 40 mg/kg/day of resveratrol had protective effects on bone quality deterioration caused by ovariectomy. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Springer Japan Kk | en_US |
dc.relation.ispartof | Journal of Bone and Mineral Metabolism | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Osteoporosis | en_US |
dc.subject | Resveratrol | en_US |
dc.subject | Ovariectomy | en_US |
dc.subject | Bone biology | en_US |
dc.subject | Raman spectroscopy | en_US |
dc.subject | Osteoporosis | en_US |
dc.subject | Supplementation | en_US |
dc.subject | Fragility | en_US |
dc.subject | Hormone | en_US |
dc.subject | Mepe | en_US |
dc.subject | Rats | en_US |
dc.title | Resveratrol prevents ovariectomy-induced bone quality deterioration by improving the microarchitectural and biophysicochemical properties of bone | en_US |
dc.type | Article | en_US |
dc.department | Pamukkale University | en_US |
dc.authorid | Altıntaş, Fatih/0000-0001-8779-0110 | - |
dc.authorid | Cort Donmez, Aysegul/0000-0001-8946-7173 | - |
dc.identifier.doi | 10.1007/s00774-023-01416-z | - |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.authorscopusid | 58174451300 | - |
dc.authorscopusid | 57204310977 | - |
dc.authorscopusid | 58175150500 | - |
dc.authorscopusid | 55968558200 | - |
dc.authorscopusid | 57940978300 | - |
dc.authorscopusid | 57193904264 | - |
dc.authorscopusid | 56303951600 | - |
dc.authorwosid | Altıntaş, Fatih/ABF-5161-2021 | - |
dc.authorwosid | Cort Donmez, Aysegul/HJY-8866-2023 | - |
dc.identifier.pmid | 37031330 | en_US |
dc.identifier.scopus | 2-s2.0-85152073859 | en_US |
dc.identifier.wos | WOS:000967277900001 | en_US |
dc.institutionauthor | … | - |
dc.identifier.scopusquality | Q2 | - |
item.grantfulltext | none | - |
item.languageiso639-1 | en | - |
item.fulltext | No Fulltext | - |
item.openairetype | Article | - |
item.cerifentitytype | Publications | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
crisitem.author.dept | 14.03. Basic Medical Sciences | - |
crisitem.author.dept | 14.03. Basic Medical Sciences | - |
crisitem.author.dept | 14.03. Basic Medical Sciences | - |
Appears in Collections: | PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection Tıp Fakültesi Koleksiyonu WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
CORE Recommender
SCOPUSTM
Citations
5
checked on Oct 13, 2024
WEB OF SCIENCETM
Citations
5
checked on Oct 22, 2024
Page view(s)
58
checked on Aug 24, 2024
Google ScholarTM
Check
Altmetric
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.